dpp 4 inhibitor glp 1 agonist It's the first in a class of drugs called DPP-4 inhibitors GLP 1 Receptor Agonists and
Description
Exenatide once weekly over 2 years as a potential disease-modifying treatment for Parkinsons disease: Protocol for a multicentre, randomised, double blind, parallel group, placebo controlled, phase 3 trial: The Exenatide-PD3 study

Neuron 69, 664679

New alert for GLP-1 agonist shortages Supply of most GLP-1 agonists will continue to be constrained until at least the end of 2024, prescribers have been warned, as a result of increased demand for 'licensed and off-label indications'
While the price of $149 for the starting dose is lower than what the companies currently offer for the injectable drugs, that price is only for the initial, lowest dose

Across the trials, ARD values ranged from + 0.6% to + 17%

Insulin therapy is also used in treating T2DM
